# EDGAR Filing Document

**Accession Number:** 0001955468
**File Stem:** 0001477932-23-000055
**Filing Date:** 2023-1
**Character Count:** 5534
**Document Hash:** 7147f060a2ff615f61a3983d17c83bb2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-23-000055.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001477932-23-000055

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230101

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Starke Clifford
- **CENTRAL INDEX KEY:** 0001955468

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40397
- **FILM NUMBER:** 23502396

**MAIL ADDRESS:**
- **STREET 1:** C/O FLORA GROWTH CORP.
- **STREET 2:** 3405 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Flora Growth Corp.
- **CENTRAL INDEX KEY:** 0001790169
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3406 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312
- **BUSINESS PHONE:** 416-861-2267

**MAIL ADDRESS:**
- **STREET 1:** 3406 SW 26TH TERRACE, SUITE C-1
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33312

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Starke Clifford<br><sub>(Last) (First) (Middle)</sub><br>C/O FLORA GROWTH CORP.<br>3405 SW 26TH TERRACE, SUITE C-1<br><sub>(Street)</sub><br>FORT LAUDERDALE, Z4 M5H 2V1<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Flora Growth Corp. [ FLGC ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-01-05:00 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_President_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Shares<sup>(1)</sup> | 2922889<sup>(2)</sup> | D |  |
| Common Shares | 671583 | I | See Footnote<sup>(3)</sup> |
| Common Shares | 6006934 | I | See Footnote<sup>(4)</sup> |
| Common Shares | 116407 | I | See Footnote<sup>(5)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) These Common Shares contain restricted share grants to the Reporting Person by the issuer as further described in footnote (2) below.

(2) The Common Shares reported include 100,000 Restricted Common Shares which vest on December 23, 2023.

(3) These securities are held by BTF Investments, Inc., of which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by BTF Investments, Inc. except to the extent of his pecuniary interest therein.

(4) These securities are held by Hampstead Private Capital Limited, of which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by Hampstead Private Capital Limited except to the extent of his pecuniary interest therein.

(5) These securities are held by YT Research, Inc., of which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by YT Research, Inc. except to the extent of his pecuniary interest therein.

**Signature:** /s/ Matthew Cohen, Attorney-in-Fact for Clifford Starke  
**Date:** 2023-01-03-05:00

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**